Target intelligence / Profile preview

CFAP65 antisense RNA 1 (CFAP65-AS1)

Target: CFAP65-AS1
Molecular classification: Long non-coding RNA (lncRNA), Other

Overview

CFAP65 antisense RNA 1 (CFAP65-AS1) is a long non-coding RNA gene located antisense to the protein-coding CFAP65 gene. While numerous lncRNAs play regulatory roles in gene expression and disease, there is currently no peer-reviewed evidence linking CFAP65-AS1 to any established molecular function, pathological process, or therapeutic application. It is not classified as a receptor, enzyme, transporter, or any established druggable target. There are no known drugs that target or interact with CFAP65-AS1, and its role in human biology remains to be elucidated. Note: There are other antisense lncRNAs (such as AFAP1-AS1) that have been implicated in cancer biology, but those are unrelated to CFAP65-AS1 and should not be confused with this target[2][4]. Information associating CFAP65-AS1 with any therapeutic or diagnostic role is lacking in current high-quality scientific sources as of 2025.

Other names: CFAP65-AS1CFAP65 antisense RNA 1

Mechanism of action

None known

Biological functions

Unknown (No experimentally validated functions available in the scientific literature or major databases as of 2025)

Disease associations

None established (No publications linking CFAP65-AS1 to specific diseases as a causal or biomarker gene)

Beyond the preview

Go deeper on CFAP65 antisense RNA 1 (CFAP65-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CFAP65 antisense RNA 1 (CFAP65-AS1).

Explore the full profile